Question 1

When was Biocon founded?

Accepted Answer

Biocon was founded in 1978.

Question 2

Who is the Founder of Biocon ?

Accepted Answer

Siddharth Mittal is the founder of Biocon.

Question 3

How much revenue does Biocon generate?

Accepted Answer

Biocon generates $867.8M in revenue.

Question 4

How much funding does Biocon have?

Accepted Answer

Biocon has raised $632.4M in funding.

Question 5

Where is Biocon headquarters?

Accepted Answer

Biocon headquarters is in Hosur Road, Electronics City, Bangalore, Karnataka 560100, IN.

Question 6

How many employees does Biocon have?

Accepted Answer

Biocon has 10682 employees.

Question 7

What sector does Biocon operate in?

Accepted Answer

Biocon is in biotech sector.

Question 8

What does Biocon Do ?

Accepted Answer

Biocon: Enhancing Global HealthcareBiocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global healthcare through innovative and affordable biopharmaceuticals, we have enabled access to advanced therapies for diseases that are chronic, where medical needs are largely unmet and treatment costs are high. The early anticipation of the increasing dominance of biologics in global development pipelines helped us to be ahead of the curve in crafting a differentiated product portfolio based on fermentation and recombinant technologies, which straddles fermentation-derived small molecules and biologics, both novel as well as biosimilars.The significant brand equity that we have built worldwide for our small molecule APIs across statins, immunosuppresants and other specialty products has made us a leading global supplier of these products.We have also built one of the largest and most diverse biosimilar pipelines, spanning insulins, monoclonal antibodies and other recombinant proteins that address critical chronic diseases such as diabetes, cancer and autoimmune disorders.Ranked among the Top 3 biosimilar players globally for rh-insulin and insulin glargine in volume terms, we are the first Indian company to launch a biosimilar in Japan with Insulin Glargine, which also has been approved for sale in EU and Australia. Our insulin products have made a difference to the lives of millions of people with diabetes across the globe. We now aim to provide our insulin products to u2018one in fiveu2019 people with diabetes in need of insulin-based therapy anywhere in the world within the next 10 years.We are also making a huge impact in the area of cancer care. Our biosimilar Trastuzumab, which was the first to be approved anywhere in the world and launched in India in 2014, has helped treat several thousand HER2-positive metastatic breast cancer patients. We are also the first company from India to get its biosimilar approved by the USFDA; Ogivriu2122, co-developed by Biocon and Mylan, is the first biosimilar Trastuzumab to be approved in the US. In addition to Trastuzumab, several of our biosimilar assets are on track for anticipated regulatory approvals in developed markets.We are also developing a pipeline of patented biologics to address global unmet medical needs. We have successfully launched a couple of novel biologics in India: Nimotuzumab for the treatment of head and neck cancer and Itolizumab to tackle psoriasis. Besides these, we have a basket of novel assets are under various stages of clinical development, including a high potential oral insulin.Through our subsidiary, Syngene, we offer a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) to the global life sciences sector.Ranked by the prestigious Science magazine among the Top 10 Best employers in the biotech industry, Biocon is passionately pursuing a mission to rationalize healthcare spends, enhance access to life-saving therapies and make a significant impact to global healthcare through u2018blockbusteru2019 drugs with the potential to benefit a billion patients.

Question 9

What is the Legal Name of Biocon ?

Accepted Answer

The legal name of Biocon is Biocon.

Question 10

Who is Biocon ceo?

Accepted Answer

Biocon ceo is Siddharth Mittal.

Question 11

Is Biocon an Indian Company ?

Accepted Answer

Yes, Biocon is an Indian Company.

Question 12

When was Biocon incorporated ?

Accepted Answer

Biocon was incorporate on 1978

Question 13

What is the registered address of Biocon  ?

Accepted Answer

The registered address of Biocon is Hosur Road, Electronics City, Bangalore, Karnataka 560100, IN

Trademark Name/Patent Name	Application No	Date

We are unable to find trademarks of Biocon as on December 4, 2025

Biocon Trademarks and Patents

Biocon- Phone & Email of Top Employees & Directors

Avanish Kumar

Winnie Joy

Bharath kuamr salva

Rakesh Maganti

Punarjit Kundu

Sarang Sangai

Shilpa Sangameswaran

Mohan Raj T

Kulvinder Singh Bhatia

ARUN GUPTA

Download our free EasyLeadz Chrome extension. Find contact numbers for 250M+ people on Internet directly.

The most accurate data ever

Support

Company

Email us